BCLI Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

$3.51
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
10/31/2003
31,567,592
1,173,058
$110,802,248
0.00%
SEC Edgar Online
10-Q
10-K
10501E201
US10501E2019
BQQFDM3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
3.48
0.00
-89.70%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy